Following the article entitled Metronomic therapy can increase quality of life during paediatric palliative cancer care, but careful patient selection is essential by Porkholm published in Acta Paediatr 2016 the editors have asked us to write an acompgnying short editorial piece.
Metronomic chemotherapy (MC) is low-dose chemotherapy that is administered frequently and without extended drug-free breaks [1]. In clinical practice, MC is often combined with drugs that were not originally (…)